Period of time： 2012年5期
Publisher： Adis International
Founded in： 1994
Total resources： 114
ISSN： 1173-8804
Subject： R4 Clinical Medicine
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
BioDrugs,volume 25,issue 5
Menu
Advances in Liver Cancer Antibody Therapies: A Focus on Glypican-3 and Mesothelin
BioDrugs,volume 25,issue 5 , Vol. 25, Iss. 5, 2011-10 , pp.
Access to resources
Recommend
New Strategies for the Development of H5N1 Subtype Influenza Vaccines: Progress and Challenges
BioDrugs,volume 25,issue 5 , Vol. 25, Iss. 5, 2011-10 , pp.Sunitinib: In Advanced, Well Differentiated Pancreatic Neuroendocrine Tumors
BioDrugs,volume 25,issue 5 , Vol. 25, Iss. 5, 2011-10 , pp.Nanofiltered Human C1 Inhibitor Concentrate (Cinryze®): In Hereditary Angioedema
By Lyseng-Williamson Katherine A. in (2011)
BioDrugs,volume 25,issue 5 , Vol. 25, Iss. 5, 2011-10 , pp.By Croxtall Jamie D. in (2011)
BioDrugs,volume 25,issue 5 , Vol. 25, Iss. 5, 2011-10 , pp.Spotlight on Lenalidomide in Relapsed or RefractoryMultiple Myeloma†
By Scott Lesley J.,Lyseng-Williamson Katherine A. in (2011)
BioDrugs,volume 25,issue 5 , Vol. 25, Iss. 5, 2011-10 , pp.By McCormack Paul L. in (2011)
BioDrugs,volume 25,issue 5 , Vol. 25, Iss. 5, 2011-10 , pp.